首页 > 最新文献

Caspian Journal of Internal Medicine最新文献

英文 中文
Mesalazine vs. IBS-D: Examining its impact on patient symptoms & stool calprotectin levels: A randomized double-blind, placebo-controlled trial. 美沙拉嗪与IBS-D:检查其对患者症状和粪便钙保护蛋白水平的影响:一项随机双盲,安慰剂对照试验。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.667
Mohammad Hossein Somi, Masoud Faghieh Dinavari, Behnam Sajedi, Sayyed Mehdi Rasooli Manesh, Faraz Mahdizadeh, Farzad Heydari

Background: Irritable bowel syndrome (IBS) is the most common disorder of the gastrointestinal system. The study aimed to determine the effect of Mesalazine prescription on patients' symptoms and level of fecal calprotectin in patients with IBS with predominant diarrhea and high fecal calprotectin.

Methods: We conducted a double-blinded randomized clinical trial with 90 patients aged 18 to 45. These patients were selected from referrals to the gastroenterology clinic. They were evenly divided into two groups: the Mesalazine group, with an average age of 35.4, and the placebo group, with an average age of 36. The patients in both groups were then monitored for 8 weeks. There were no differences in the distribution of sexes between the two groups.

Results: In comparison between before and after Mesalazine therapy in our patients marked a statistically significant effect on the quality of life variables (p<0.05), patient's level of pain (p<0.05), abdominal distension (p<0.05), and calprotectin level (p<0.05) compared to before Mesalazine in patients studied, which showed the effectiveness of this treatment. However its effect on stool form was not significant (P=0.11).

Conclusion: Comparing the two groups after the intervention, the quality of life in patients treated with Mesalazine was significantly higher than in patients of the placebo group. The number of defecations in patients treated with Mesalazine was significantly lower than in patients of placebo groups. Abdominal distention and calprotectin levels were significantly lower in these patients than in patients of the placebo group.

背景:肠易激综合征(IBS)是最常见的胃肠系统疾病。本研究旨在确定美沙拉嗪处方对以腹泻为主、粪钙保护蛋白高的IBS患者的症状和粪钙保护蛋白水平的影响。方法:对90例18 ~ 45岁的患者进行双盲随机临床试验。这些患者是从转介到胃肠病学诊所中挑选出来的。他们被平均分为两组:美沙拉嗪组,平均年龄35.4岁;安慰剂组,平均年龄36岁。两组患者随访8周。两组之间的性别分布没有差异。结果:美沙拉嗪治疗前后对我们患者生活质量变量的影响有统计学意义(p)结论:干预后两组患者美沙拉嗪治疗后的生活质量明显高于安慰剂组患者。用美沙拉嗪治疗的患者排便次数明显低于安慰剂组。这些患者的腹胀和钙保护蛋白水平明显低于安慰剂组。
{"title":"Mesalazine vs. IBS-D: Examining its impact on patient symptoms & stool calprotectin levels: A randomized double-blind, placebo-controlled trial.","authors":"Mohammad Hossein Somi, Masoud Faghieh Dinavari, Behnam Sajedi, Sayyed Mehdi Rasooli Manesh, Faraz Mahdizadeh, Farzad Heydari","doi":"10.22088/cjim.16.4.667","DOIUrl":"10.22088/cjim.16.4.667","url":null,"abstract":"<p><strong>Background: </strong>Irritable bowel syndrome (IBS) is the most common disorder of the gastrointestinal system. The study aimed to determine the effect of Mesalazine prescription on patients' symptoms and level of fecal calprotectin in patients with IBS with predominant diarrhea and high fecal calprotectin.</p><p><strong>Methods: </strong>We conducted a double-blinded randomized clinical trial with 90 patients aged 18 to 45. These patients were selected from referrals to the gastroenterology clinic. They were evenly divided into two groups: the Mesalazine group, with an average age of 35.4, and the placebo group, with an average age of 36. The patients in both groups were then monitored for 8 weeks. There were no differences in the distribution of sexes between the two groups.</p><p><strong>Results: </strong>In comparison between before and after Mesalazine therapy in our patients marked a statistically significant effect on the quality of life variables (p<0.05), patient's level of pain (p<0.05), abdominal distension (p<0.05), and calprotectin level (p<0.05) compared to before Mesalazine in patients studied, which showed the effectiveness of this treatment. However its effect on stool form was not significant (P=0.11).</p><p><strong>Conclusion: </strong>Comparing the two groups after the intervention, the quality of life in patients treated with Mesalazine was significantly higher than in patients of the placebo group. The number of defecations in patients treated with Mesalazine was significantly lower than in patients of placebo groups. Abdominal distention and calprotectin levels were significantly lower in these patients than in patients of the placebo group.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"667-673"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid endarterectomy on the course of the acute period of ischemic stroke and chronic cerebral ischemia. 颈动脉内膜切除术对缺血性脑卒中和慢性脑缺血急性期病程的影响。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.659
Aiym Sakhipova

Background: Carotid endarterectomy (CE) is currently the main surgical treatment and preventative measure for ischemic stroke (IS) in patients with atherosclerotic stenosis and carotid artery occlusion; however, there are no clear opinions regarding the effect of CE on the course of the acute period of IS and chronic cerebral ischemia (CCI).

Methods: The study included 186 patients aged 45-81 years. The study population comprised two observation groups: group I included 131 patients with internal carotid artery (ICA) stenosis of more than 60% with unstable atherosclerotic plaque who underwent CE, and group II included 55 patients with ICA stenosis 60% with stable atherosclerotic plaque who did not undergo surgical treatment. The SPSS 21 package was used for statistical analysis.

Results: The results of the NIHSS, Rankin, and Rivermead scales after 12 months indicated a significant positive dynamic of the neurological status in patients in the first group (2.33±0.30 in the first group and 0.89±0.12 in the comparison group, p < 0.05). In the acute period of IS, CE performed according to indications led to a decrease in neurological symptoms (80.9% of patients scored 0-3 points on the NIHSS scale), a decrease in the degree of disability, and an increase in mobility in patients.

Conclusion: In patients who underwent the operation, disability was significantly lower 1 year after IS.

背景:颈动脉内膜切除术(CE)是目前动脉粥样硬化性狭窄和颈动脉闭塞患者缺血性卒中(is)的主要手术治疗和预防措施;然而,CE对IS急性期病程和慢性脑缺血(CCI)的影响尚无明确的观点。方法:纳入186例患者,年龄45 ~ 81岁。研究人群分为两个观察组:1组131例颈内动脉(ICA)狭窄60%以上且伴有不稳定斑块的患者行CE, 2组55例颈内动脉(ICA)狭窄60%以上且伴有稳定斑块的患者行CE。采用SPSS 21软件包进行统计分析。结果:12个月后NIHSS、Rankin、Rivermead评分结果显示,第一组患者神经功能状态显著改善(第一组为2.33±0.30,对照组为0.89±0.12,p < 0.05)。在IS急性期,根据适应症进行CE治疗,神经系统症状减轻(80.9%的患者NIHSS评分为0-3分),残疾程度降低,患者活动能力增加。结论:接受手术的患者在IS术后1年的致残率明显降低。
{"title":"Carotid endarterectomy on the course of the acute period of ischemic stroke and chronic cerebral ischemia.","authors":"Aiym Sakhipova","doi":"10.22088/cjim.16.4.659","DOIUrl":"10.22088/cjim.16.4.659","url":null,"abstract":"<p><strong>Background: </strong>Carotid endarterectomy (CE) is currently the main surgical treatment and preventative measure for ischemic stroke (IS) in patients with atherosclerotic stenosis and carotid artery occlusion; however, there are no clear opinions regarding the effect of CE on the course of the acute period of IS and chronic cerebral ischemia (CCI).</p><p><strong>Methods: </strong>The study included 186 patients aged 45-81 years. The study population comprised two observation groups: group I included 131 patients with internal carotid artery (ICA) stenosis of more than 60% with unstable atherosclerotic plaque who underwent CE, and group II included 55 patients with ICA stenosis 60% with stable atherosclerotic plaque who did not undergo surgical treatment. The SPSS 21 package was used for statistical analysis.</p><p><strong>Results: </strong>The results of the NIHSS, Rankin, and Rivermead scales after 12 months indicated a significant positive dynamic of the neurological status in patients in the first group (2.33±0.30 in the first group and 0.89±0.12 in the comparison group, p < 0.05). In the acute period of IS, CE performed according to indications led to a decrease in neurological symptoms (80.9% of patients scored 0-3 points on the NIHSS scale), a decrease in the degree of disability, and an increase in mobility in patients.</p><p><strong>Conclusion: </strong>In patients who underwent the operation, disability was significantly lower 1 year after IS.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"659-666"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between vitamin D levels and urinary tract infections. 维生素D水平与尿路感染之间的关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.651
Masoumeh Piyadah Kouhsar, Morteza Alijanpour, Mohammad Pournasrullah, Hemat Gholinia, Sahar Sadr Moharerpour

Background: Urinary tract infections (UTIs) are among the most prevalent infectious conditions, particularly in children. Vitamin D deficiency has been implicated in various infections, including UTIs. This study aimed to evaluate the association between serum vitamin D levels and UTIs in children at Amir Kola Children's Hospital.

Methods: This case-control study was conducted on 120 children, aged 2-18 years, diagnosed with UTIs and referred to Amir Kola Children's Hospital, Babol, Iran. Participants were divided into two groups: 60 UTI cases and 60 healthy controls. Peripheral blood samples were collected for vitamin D analysis, measured via ELISA assay. Statistical analysis was performed using SPSS Version 26.

Results: The mean serum vitamin D level was 17.70±8.35 ng/mL in the case group and 37.91±12.18 ng/mL in the control group, revealing a significant reduction in vitamin D levels among UTI patients (P<0.001). Additionally, pyelonephritis was associated with severe vitamin D deficiency (P=0.02). Female children aged 3-5 years exhibited a higher risk of vitamin D deficiency, although age and sex did not significantly influence vitamin D levels overall. Vitamin D status was not correlated with hospitalization duration.

Conclusion: Given its immunoprotective role, vitamin D screening and supplementation may serve as a preventive strategy against UTIs and contribute to improved clinical outcomes in affected children.

背景:尿路感染(uti)是最普遍的感染性疾病之一,特别是在儿童中。维生素D缺乏与各种感染有关,包括尿路感染。本研究旨在评估阿米尔科拉儿童医院儿童血清维生素D水平与尿路感染之间的关系。方法:本病例对照研究对120名年龄在2-18岁,诊断为尿路感染并转诊至伊朗巴博勒Amir Kola儿童医院的儿童进行了研究。参与者分为两组:60例尿路感染病例和60例健康对照。采集外周血进行维生素D分析,ELISA法测定。采用SPSS Version 26进行统计分析。结果:病例组的平均血清维生素D水平为17.70±8.35 ng/mL,对照组的平均血清维生素D水平为37.91±12.18 ng/mL,表明尿路感染患者的维生素D水平显著降低(结论:鉴于其免疫保护作用,维生素D筛查和补充可能作为预防尿路感染的策略,有助于改善感染儿童的临床结果。
{"title":"Association between vitamin D levels and urinary tract infections.","authors":"Masoumeh Piyadah Kouhsar, Morteza Alijanpour, Mohammad Pournasrullah, Hemat Gholinia, Sahar Sadr Moharerpour","doi":"10.22088/cjim.16.4.651","DOIUrl":"10.22088/cjim.16.4.651","url":null,"abstract":"<p><strong>Background: </strong>Urinary tract infections (UTIs) are among the most prevalent infectious conditions, particularly in children. Vitamin D deficiency has been implicated in various infections, including UTIs. This study aimed to evaluate the association between serum vitamin D levels and UTIs in children at Amir Kola Children's Hospital.</p><p><strong>Methods: </strong>This case-control study was conducted on 120 children, aged 2-18 years, diagnosed with UTIs and referred to Amir Kola Children's Hospital, Babol, Iran. Participants were divided into two groups: 60 UTI cases and 60 healthy controls. Peripheral blood samples were collected for vitamin D analysis, measured via ELISA assay. Statistical analysis was performed using SPSS Version 26.</p><p><strong>Results: </strong>The mean serum vitamin D level was 17.70±8.35 ng/mL in the case group and 37.91±12.18 ng/mL in the control group, revealing a significant reduction in vitamin D levels among UTI patients (P<0.001). Additionally, pyelonephritis was associated with severe vitamin D deficiency (P=0.02). Female children aged 3-5 years exhibited a higher risk of vitamin D deficiency, although age and sex did not significantly influence vitamin D levels overall. Vitamin D status was not correlated with hospitalization duration.</p><p><strong>Conclusion: </strong>Given its immunoprotective role, vitamin D screening and supplementation may serve as a preventive strategy against UTIs and contribute to improved clinical outcomes in affected children.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"651-658"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review and meta-analysis of the prevalence of celiac disease in migraine patients. 偏头痛患者乳糜泻患病率的系统回顾和荟萃分析。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.621
Gholamreza Kalvandi, Naser Nasiri, Parya Jangipour Afshar, Hosna Ghaderi, Farzad Faizi, Shoboo Rahmati

Background: Celiac disease (CD) is a gluten-induced autoimmune disorder that can present with gastrointestinal, extraintestinal, or no symptoms. The prevalence of CD in migraine patients and the nature of their potential association is not well established. Therefore, the purpose of this study was to investigate the prevalence of CD in migraine patients using a systematic review and meta-analysis.

Methods: PRISMA guidelines created a framework for the construction of this review article. Two investigators independently searched the electronic databases of Scopus, PubMed, Web of Science and Google Scholar search engine up to May 2024. To assess heterogeneity among the studies, we used Cochran's Q test and the I² index. The statistical analyses were performed using Stata software, version 14.2, and a p-value of less than 0.05 was considered statistically significant.

Results: This meta-analysis included a total of 6 articles, comprising 14,526 migraine patients. The overall prevalence of CD in migraine patients was estimated to be (2% (95% CI: 0%-5%, I2=75.37, P=0.001)). Also, the Odds of CD disease in migraine patients compared to non-migraine patients was estimated to be equal (2.20 (95% CI: 0.87-5.54, I2=48.4, P=0.121)). Additionally, the majority of the research was conducted in Europe.

Conclusions: Although the small amount of research accomplished in this particular situation, our data indicate a relatively low prevalence of CD in migraine patients. Therefore, more frequent and thorough research in this field is advised. Patients with migraines experienced fewer attacks when they received gluten-free diets and were screened for celiac disease.

背景:乳糜泻(CD)是一种麸质诱导的自身免疫性疾病,可表现为胃肠道、肠外或无症状。偏头痛患者中乳糜泻的患病率及其潜在关联的性质尚未得到很好的确定。因此,本研究的目的是通过系统回顾和荟萃分析来调查偏头痛患者CD的患病率。方法:PRISMA指南为本综述文章的构建建立了框架。两位研究者独立检索了截止到2024年5月的Scopus、PubMed、Web of Science和b谷歌Scholar搜索引擎的电子数据库。为了评估研究之间的异质性,我们使用了科克伦Q检验和I²指数。统计学分析采用Stata软件14.2版进行,p值小于0.05认为有统计学意义。结果:本荟萃分析共纳入6篇文章,包括14526名偏头痛患者。偏头痛患者CD的总体患病率估计为(2% (95% CI: 0%-5%, I2=75.37, P=0.001))。此外,偏头痛患者与非偏头痛患者相比,CD疾病的几率估计相等(2.20 (95% CI: 0.87-5.54, I2=48.4, P=0.121))。此外,大多数研究是在欧洲进行的。结论:虽然在这种特殊情况下完成的研究数量很少,但我们的数据表明偏头痛患者中CD的患病率相对较低。因此,建议在这一领域进行更频繁和深入的研究。当偏头痛患者接受无麸质饮食并接受乳糜泻筛查时,偏头痛发作的次数会减少。
{"title":"A systematic review and meta-analysis of the prevalence of celiac disease in migraine patients.","authors":"Gholamreza Kalvandi, Naser Nasiri, Parya Jangipour Afshar, Hosna Ghaderi, Farzad Faizi, Shoboo Rahmati","doi":"10.22088/cjim.16.4.621","DOIUrl":"10.22088/cjim.16.4.621","url":null,"abstract":"<p><strong>Background: </strong>Celiac disease (CD) is a gluten-induced autoimmune disorder that can present with gastrointestinal, extraintestinal, or no symptoms. The prevalence of CD in migraine patients and the nature of their potential association is not well established. Therefore, the purpose of this study was to investigate the prevalence of CD in migraine patients using a systematic review and meta-analysis.</p><p><strong>Methods: </strong>PRISMA guidelines created a framework for the construction of this review article. Two investigators independently searched the electronic databases of Scopus, PubMed, Web of Science and Google Scholar search engine up to May 2024. To assess heterogeneity among the studies, we used Cochran's Q test and the I² index. The statistical analyses were performed using Stata software, version 14.2, and a p-value of less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>This meta-analysis included a total of 6 articles, comprising 14,526 migraine patients. The overall prevalence of CD in migraine patients was estimated to be (2% (95% CI: 0%-5%, I<sup>2</sup>=75.37, P=0.001)). Also, the Odds of CD disease in migraine patients compared to non-migraine patients was estimated to be equal (2.20 (95% CI: 0.87-5.54, I2=48.4, P=0.121)). Additionally, the majority of the research was conducted in Europe.</p><p><strong>Conclusions: </strong>Although the small amount of research accomplished in this particular situation, our data indicate a relatively low prevalence of CD in migraine patients. Therefore, more frequent and thorough research in this field is advised. Patients with migraines experienced fewer attacks when they received gluten-free diets and were screened for celiac disease.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"621-629"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative efficacy of extra virgin olive oil versus refined olive oil in the treatment of individuals suffering from constipation: A double-blind randomized clinical trial study. 特级初榨橄榄油与精制橄榄油在治疗便秘患者中的比较疗效:一项双盲随机临床试验研究。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.674
Farahnaz Joukar, Seyedeh Narjes Mozaffari Chenijani, Saman Maroufizadeh, Tahereh Zeinali, Niloofar Faraji, Narges Eslami, Fariborz Mansour-Ghanaei

Background: Evidence suggested that olive oil may alleviate constipation symptoms. This study compared the effectiveness of two types of extra virgin olive oil and refined olive oil on the treatment of patients experiencing constipation.

Methods: This double-blind clinical trial included 140 participants aged 18 years or older who were diagnosed with chronic constipation by a gastroenterologist using the Rome III questionnaire. Block randomization was utilized approach to divide patients into two groups of 70 individuals (Extra virgin olive oil as trial and refined olive oil as control) that consumed two tablespoons per day of olive oil for four weeks. Follow-up assessments were conducted using the Rome III and Bristol Stool Form Scale (BSFS) questionnaires.

Results: According to analysis of covariance (ANCOVA), after four weeks of the intervention, the mean score of Rome III decreased significantly from 11.37±2.25 to 7.74±2.53; and from 11.27±2.73 to 3.47±1.73 among refined olive oil and extra virgin olive oil consumers, respectively, (-4.22 (95% CI: 3.63-4.82), (F (1,137) =197.67, p<0.001, η2P=0.591). In week 2,3, and 4, the mean score of BSFS were significantly higher among consumers of extra virgin olive oil than to the consumers of refined olive oil 0.53 (95% CI: 0.38- 0.68), p<0.001, 0.78 (95% CI: 0.60- 0.97), p<0.001 and 1.14 (95% CI: 0.94-1.35), p<0.001, respectively.

Conclusion: Extra virgin olive oil was more effective compared refined olive oil at alleviating constipation. These outcomes highlight the importance of extra virgin olive oil as a possible treatment for constipation.

背景:有证据表明橄榄油可以缓解便秘症状。这项研究比较了两种特级初榨橄榄油和精制橄榄油对便秘患者的治疗效果。方法:这项双盲临床试验包括140名18岁或以上的参与者,他们由胃肠病学家使用Rome III问卷诊断为慢性便秘。采用分组随机方法将患者分为两组,每组70人(特级初榨橄榄油作为试验,精制橄榄油作为对照),每天食用两汤匙橄榄油,持续四周。使用Rome III和Bristol大便形式量表(BSFS)问卷进行随访评估。结果:经协方差分析(ANCOVA),干预4周后,患者的Rome III平均评分由11.37±2.25分显著下降至7.74±2.53分;精制橄榄油和特级初榨橄榄油消费者的便秘指数分别为11.27±2.73 ~ 3.47±1.73,分别为-4.22 (95% CI: 3.63 ~ 4.82), F (1137) =197.67, p结论:特级初榨橄榄油比精制橄榄油更有效缓解便秘。这些结果突出了特级初榨橄榄油作为一种可能治疗便秘的重要性。
{"title":"Comparative efficacy of extra virgin olive oil versus refined olive oil in the treatment of individuals suffering from constipation: A double-blind randomized clinical trial study.","authors":"Farahnaz Joukar, Seyedeh Narjes Mozaffari Chenijani, Saman Maroufizadeh, Tahereh Zeinali, Niloofar Faraji, Narges Eslami, Fariborz Mansour-Ghanaei","doi":"10.22088/cjim.16.4.674","DOIUrl":"10.22088/cjim.16.4.674","url":null,"abstract":"<p><strong>Background: </strong>Evidence suggested that olive oil may alleviate constipation symptoms. This study compared the effectiveness of two types of extra virgin olive oil and refined olive oil on the treatment of patients experiencing constipation.</p><p><strong>Methods: </strong>This double-blind clinical trial included 140 participants aged 18 years or older who were diagnosed with chronic constipation by a gastroenterologist using the Rome III questionnaire. Block randomization was utilized approach to divide patients into two groups of 70 individuals (Extra virgin olive oil as trial and refined olive oil as control) that consumed two tablespoons per day of olive oil for four weeks. Follow-up assessments were conducted using the Rome III and Bristol Stool Form Scale (BSFS) questionnaires.</p><p><strong>Results: </strong>According to analysis of covariance (ANCOVA), after four weeks of the intervention, the mean score of Rome III decreased significantly from 11.37±2.25 to 7.74±2.53; and from 11.27±2.73 to 3.47±1.73 among refined olive oil and extra virgin olive oil consumers, respectively, (-4.22 (95% CI: 3.63-4.82), (F (<sub>1,137</sub>) =197.67, p<0.001, η2P=0.591). In week 2,3, and 4, the mean score of BSFS were significantly higher among consumers of extra virgin olive oil than to the consumers of refined olive oil 0.53 (95% CI: 0.38- 0.68), p<0.001, 0.78 (95% CI: 0.60- 0.97), p<0.001 and 1.14 (95% CI: 0.94-1.35), p<0.001, respectively.</p><p><strong>Conclusion: </strong>Extra virgin olive oil was more effective compared refined olive oil at alleviating constipation. These outcomes highlight the importance of extra virgin olive oil as a possible treatment for constipation.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"674-685"},"PeriodicalIF":1.0,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the gap: Exploring the intercurrent relationship between knee osteoarthritis and cerebral small vessel disease. 弥合差距:探讨膝关节骨关节炎与脑血管疾病的相互关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-14 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.599
Mazira Mohamad Ghazali, Nor Farid Mohd Noor, Muhamad Afiq Mahayidin, Mohd Nasir Mat Nor, Che Mohd Nasril Che Mohd Nassir

Knee osteoarthritis (KOA) and cerebral small vessel disease (CSVD) are two prevalent and debilitating conditions that have traditionally been studied within distinct medical disciplines - rheumatology and neurology, respectively. However, emerging evidence suggests a deeper connection between these seemingly disparate diseases, transcending conventional boundaries and prompting a paradigm shift in our understanding of their pathophysiology and clinical implications. This narrative review explores the multifaceted crosstalk between KOA and CSVD, delving into shared risk factors, inflammatory cascades, and vascular mechanisms underpinning their co-occurrence. Beyond conventional etiological factors, we illuminate the role of systemic inflammation, aberrant biomechanics, and neuro-gliovascular interactions in shaping the complex interplay between KOA and CSVD. Furthermore, we scrutinize the bidirectional impact of these conditions on cognitive function, emphasizing the shared burden of neurocognitive impairment in affected individuals. Through a synthesis of cutting-edge research and theoretical frameworks, we propose a novel conceptual model that integrates musculoskeletal and cerebrovascular pathways, shedding light on previously unexplored avenues for therapeutic intervention and personalized management strategies. This comprehensive analysis not only advances our understanding of the interconnected nature of KOA and CSVD but also underscores the imperative for interdisciplinary collaboration and holistic approaches to patient care in the era of precision medicine.

膝骨关节炎(KOA)和脑血管疾病(CSVD)是两种常见的衰弱性疾病,传统上分别在不同的医学学科-风湿病学和神经病学中进行研究。然而,新出现的证据表明,这些看似不同的疾病之间存在更深层次的联系,超越了传统的界限,并促使我们对其病理生理学和临床意义的理解发生了范式转变。这篇综述探讨了KOA和CSVD之间的多方面的相互影响,深入探讨了共同的危险因素、炎症级联反应和支持它们共同发生的血管机制。除了传统的病因因素,我们阐明了全身性炎症、异常的生物力学和神经-胶质血管相互作用在形成KOA和CSVD之间复杂的相互作用中的作用。此外,我们仔细研究了这些条件对认知功能的双向影响,强调受影响个体的神经认知障碍的共同负担。通过综合前沿研究和理论框架,我们提出了一个整合肌肉骨骼和脑血管途径的新概念模型,为治疗干预和个性化管理策略提供了以前未探索的途径。这一综合分析不仅促进了我们对KOA和CSVD相互联系性质的理解,而且强调了在精准医学时代跨学科合作和整体方法对患者护理的必要性。
{"title":"Bridging the gap: Exploring the intercurrent relationship between knee osteoarthritis and cerebral small vessel disease.","authors":"Mazira Mohamad Ghazali, Nor Farid Mohd Noor, Muhamad Afiq Mahayidin, Mohd Nasir Mat Nor, Che Mohd Nasril Che Mohd Nassir","doi":"10.22088/cjim.16.4.599","DOIUrl":"10.22088/cjim.16.4.599","url":null,"abstract":"<p><p>Knee osteoarthritis (KOA) and cerebral small vessel disease (CSVD) are two prevalent and debilitating conditions that have traditionally been studied within distinct medical disciplines - rheumatology and neurology, respectively. However, emerging evidence suggests a deeper connection between these seemingly disparate diseases, transcending conventional boundaries and prompting a paradigm shift in our understanding of their pathophysiology and clinical implications. This narrative review explores the multifaceted crosstalk between KOA and CSVD, delving into shared risk factors, inflammatory cascades, and vascular mechanisms underpinning their co-occurrence. Beyond conventional etiological factors, we illuminate the role of systemic inflammation, aberrant biomechanics, and neuro-gliovascular interactions in shaping the complex interplay between KOA and CSVD. Furthermore, we scrutinize the bidirectional impact of these conditions on cognitive function, emphasizing the shared burden of neurocognitive impairment in affected individuals. Through a synthesis of cutting-edge research and theoretical frameworks, we propose a novel conceptual model that integrates musculoskeletal and cerebrovascular pathways, shedding light on previously unexplored avenues for therapeutic intervention and personalized management strategies. This comprehensive analysis not only advances our understanding of the interconnected nature of KOA and CSVD but also underscores the imperative for interdisciplinary collaboration and holistic approaches to patient care in the era of precision medicine.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"599-620"},"PeriodicalIF":1.0,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Onabotulinumtoxin intra-detrusor injection for lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis. 逼尿肌内注射肉毒杆菌毒素治疗多发性硬化症(MS)患者下尿路症状(LUTS):一项系统综述和荟萃分析
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-14 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.4.588
Atena Soltanzadi, Omid Mirmosayyeb, Amin Momeni Moghaddam, Saeed Vaheb, Mahsa Ghajarzadeh

Background: Lower urinary tract symptoms (LUTS) are common complications in patients with multiple sclerosis (MS). Different studies evaluated the effects of Onabotulinumtoxin on urinary findings in patients with MS. We designed this systematic review and meta-analysis to estimate pooled efficacy of intra-detrusor injections of botox for urinary symptoms in patients with MS.

Methods: A comprehensive systematic search was conducted on five databases of PubMed, Scopus, EMBASE, Web of Science, and Google scholar on February 2022. . We extracted data regarding the total number of participants, first author, publication year, the country of origin, mean age, F/M ratio, duration of the disease, duration of the treatment, mean Expanded Disability Status Scale (EDSS), maximum cystometric capacity (MCC), and maximum detrusor pressure (MDP).

Results: Preliminary search of databases retrieved 1618 articles, after deduplication, 934 studies remained. Five studies were included for meta-analysis. The most frequent country of origin was the USA, and the mean EDSS ranged between 2.9 and 5.1. Urinary tract infection (UTI) and urinary retention were the most prevalent complications. The SMD of MDP (MDP week 12-MDP baseline) was -1.32(95%CI:-1.77, -0.37) (I2=52.9%, P=0.1). The SMD of MCC (MCC week 12-MCC baseline) was 1.65 (95%CI: 0.44, 2.86) (I2=92.4%, p<0.001). The SMD of MDP (MDP week 4-MDP baseline) was -3.6 (95%CI:-7.3, 0.16) (I2=98.3%, p<0.001). The SMD of MCC (MCC week 4-MCC baseline) was 5.05 (95%CI: 0.14, 9.96) (I2=98.8%, p<0.001).

Conclusions: This systematic review and meta-analysis demonstrated that injection of intra-detrusor Onabotulinumtoxin had a positive effect on improving urodynamic findings in patients with MS.

背景:下尿路症状(LUTS)是多发性硬化症(MS)患者常见的并发症。不同的研究评估了肉毒杆菌毒素对多发性硬化症患者泌尿系统症状的影响。我们设计了本系统综述和荟萃分析,以评估逼尿肌内注射肉毒杆菌毒素对多发性硬化症患者泌尿系统症状的综合疗效。方法:于2022年2月对PubMed、Scopus、EMBASE、Web of Science和谷歌scholar等5个数据库进行了全面的系统检索。我们提取了有关参与者总数、第一作者、发表年份、原籍国、平均年龄、F/M比、病程、治疗时间、平均扩展残疾状态量表(EDSS)、最大膀胱容量(MCC)和最大逼尿肌压力(MDP)的数据。结果:初步检索数据库检索文献1618篇,经重复数据删除后,剩余934篇。纳入5项研究进行荟萃分析。最常见的原产国是美国,平均EDSS在2.9至5.1之间。尿路感染和尿潴留是最常见的并发症。MDP的SMD (MDP周12-MDP基线)为-1.32(95%CI:-1.77, -0.37) (I2=52.9%, P=0.1)。MCC的SMD (MCC 12周基线)为1.65 (95%CI: 0.44, 2.86) (I2=92.4%, p4 - mdp基线)为-3.6 (95%CI:-7.3, 0.16) (I2=98.3%, p4 -MCC基线)为5.05 (95%CI: 0.14, 9.96) (I2=98.8%, p4 -MCC基线)。结论:本系统评价和荟萃分析表明,逼尿肌内注射onabotulintoxin对改善MS患者尿动力学表现有积极作用。
{"title":"Onabotulinumtoxin intra-detrusor injection for lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis.","authors":"Atena Soltanzadi, Omid Mirmosayyeb, Amin Momeni Moghaddam, Saeed Vaheb, Mahsa Ghajarzadeh","doi":"10.22088/cjim.16.4.588","DOIUrl":"10.22088/cjim.16.4.588","url":null,"abstract":"<p><strong>Background: </strong>Lower urinary tract symptoms (LUTS) are common complications in patients with multiple sclerosis (MS). Different studies evaluated the effects of Onabotulinumtoxin on urinary findings in patients with MS. We designed this systematic review and meta-analysis to estimate pooled efficacy of intra-detrusor injections of botox for urinary symptoms in patients with MS.</p><p><strong>Methods: </strong>A comprehensive systematic search was conducted on five databases of PubMed, Scopus, EMBASE, Web of Science, and Google scholar on February 2022. . We extracted data regarding the total number of participants, first author, publication year, the country of origin, mean age, F/M ratio, duration of the disease, duration of the treatment, mean Expanded Disability Status Scale (EDSS), maximum cystometric capacity (MCC), and maximum detrusor pressure (MDP).</p><p><strong>Results: </strong>Preliminary search of databases retrieved 1618 articles, after deduplication, 934 studies remained. Five studies were included for meta-analysis. The most frequent country of origin was the USA, and the mean EDSS ranged between 2.9 and 5.1. Urinary tract infection (UTI) and urinary retention were the most prevalent complications. The SMD of MDP (MDP <sub>week 12</sub>-MDP <sub>baseline</sub>) was -1.32(95%CI:-1.77, -0.37) (I<sup>2</sup>=52.9%, P=0.1). The SMD of MCC (MCC <sub>week 12</sub>-MCC <sub>baseline</sub>) was 1.65 (95%CI: 0.44, 2.86) (I<sup>2</sup>=92.4%, p<0.001). The SMD of MDP (MDP <sub>week 4</sub>-MDP <sub>baseline</sub>) was -3.6 (95%CI:-7.3, 0.16) (I<sup>2</sup>=98.3%, p<0.001). The SMD of MCC (MCC <sub>week 4</sub>-MCC <sub>baseline</sub>) was 5.05 (95%CI: 0.14, 9.96) (I<sup>2</sup>=98.8%, p<0.001).</p><p><strong>Conclusions: </strong>This systematic review and meta-analysis demonstrated that injection of intra-detrusor Onabotulinumtoxin had a positive effect on improving urodynamic findings in patients with MS.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"588-598"},"PeriodicalIF":1.0,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between eosinopenia and neutrophil-lymphocyte ratio with sepsis-related mortality in the intensive care unit. 重症监护病房中嗜酸性粒细胞减少和中性粒细胞淋巴细胞比值与败血症相关死亡率的关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.444
Parviz Amri, Armin Nejadnaderi, Hemmat Gholinia, Fatemeh Heidarnia, Masomeh Bayani

Background: Early diagnosis of sepsis can lead to rapid initiation of treatment and reduced mortality. The aim of this study was to investigate the relationship between eosinopenia and neutrophil-lymphocyte ratio (NLR) with sepsis-related mortality in the intensive care unit.

Results: Out of 100 patients studied, 59 patients survived and 41 patients died and the mean age of the patients was 63.27±16.13 years. Out of 40 patients with eosinopenia, 19(46.3%) died and out of 60 patients with normal eosinophil, 22(53.7%) died (P=0.28). The NLR on the first day in died patients was significantly higher than in the surviving patients (P=0.009). The increase in SOFA Score (p<0.001 and OR=1.49) and the increase in NLR (P=0.02 and OR=3.38) has a direct relationship with the mortality rate.

Conclusion: The results of the present study in sepsis patients showed that patients who had a higher neutrophil-to-lymphocyte ratio had higher mortality and there was no relationship between eosinopenia and mortality rate.

背景:败血症的早期诊断可以导致快速开始治疗和降低死亡率。本研究的目的是探讨重症监护病房中嗜酸性粒细胞减少和中性粒细胞淋巴细胞比(NLR)与败血症相关死亡率的关系。结果:100例患者中,存活59例,死亡41例,平均年龄63.27±16.13岁。40例嗜酸性粒细胞减少患者中死亡19例(46.3%),60例嗜酸性粒细胞正常患者中死亡22例(53.7%)(P=0.28)。死亡患者第1天NLR显著高于存活患者(P=0.009)。结论:本研究结果显示,脓毒症患者中性粒细胞与淋巴细胞比值较高的患者死亡率较高,嗜酸性粒细胞减少与死亡率无相关性。
{"title":"Relationship between eosinopenia and neutrophil-lymphocyte ratio with sepsis-related mortality in the intensive care unit.","authors":"Parviz Amri, Armin Nejadnaderi, Hemmat Gholinia, Fatemeh Heidarnia, Masomeh Bayani","doi":"10.22088/cjim.16.3.444","DOIUrl":"10.22088/cjim.16.3.444","url":null,"abstract":"<p><strong>Background: </strong>Early diagnosis of sepsis can lead to rapid initiation of treatment and reduced mortality. The aim of this study was to investigate the relationship between eosinopenia and neutrophil-lymphocyte ratio (NLR) with sepsis-related mortality in the intensive care unit.</p><p><strong>Results: </strong>Out of 100 patients studied, 59 patients survived and 41 patients died and the mean age of the patients was 63.27±16.13 years. Out of 40 patients with eosinopenia, 19(46.3%) died and out of 60 patients with normal eosinophil, 22(53.7%) died (P=0.28). The NLR on the first day in died patients was significantly higher than in the surviving patients (P=0.009). The increase in SOFA Score (p<0.001 and OR=1.49) and the increase in NLR (P=0.02 and OR=3.38) has a direct relationship with the mortality rate.</p><p><strong>Conclusion: </strong>The results of the present study in sepsis patients showed that patients who had a higher neutrophil-to-lymphocyte ratio had higher mortality and there was no relationship between eosinopenia and mortality rate.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"444-450"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seroepidemiology of toxoplasma gondii in kidney transplant patients. 肾移植患者刚地弓形虫血清流行病学研究。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.507
Marzieh Latifi, Habib Rahban, Elahe Pourhosein, Tannaz Hajialireza Tehrani, Parisa Mahjoobi, Sanaz Dehghani

Background: Opportunistic infection after transplantation is a serious problem, with Toxoplasma Gondii (T.gondii) and cytomegalovirus being the most concerning infections. The objective of this research was to examine the seroepidemiology of the T. gondii virus among kidney transplant recipients at Sina Hospital in Tehran from 2017 to 2021.

Methods: A total of 342 kidney transplant patients participated in this cross-sectional study using the census method after obtaining consent. Data were collected by reviewing medical records and the transplant database, including demographic characteristics and infectious tests related to kidney transplantation. The collected information was entered into SPSS18 software.

Results: The age of the subjects ranged from 10 to 73 years, with 125 patients having kidney failure due to ERDS. The rate of exposure to T. gondii in kidney transplant patients was 54.2%. 125 patients experiencing kidney failure due to ERDS. In kidney transplant patients, the exposure rate to T. gondii was 54.2%. There is a positive correlation between TOX IgG and age (r= 0.12, P = 0.02). There is a positive correlation between CMV IgG and the time elapsed since kidney transplantation (r = 0.11, P = 0.03) and TOX IgG (r = 0.13, p < 0.01). Gender was found not to predict EBV.IgG (β = 0.787, p < 0.21), CMV.IgG (β = 4.752, p < 0.071), TOX.IgG (β = 1.154, p < 0.256) based on regression tests.

Conclusion: Physicians should be aware of preventive measures and should consider early diagnosis in cases of compatible symptoms. Screening for anti-Toxoplasma IgM antibodies in potential donors is recommended.

背景:移植术后机会性感染是一个严重的问题,其中以弓形虫和巨细胞病毒感染最为严重。本研究的目的是检测2017年至2021年德黑兰新浪医院肾移植受者中弓形虫病毒的血清流行病学。方法:对342例肾移植患者进行横断面研究,经同意后采用普查方法。通过审查医疗记录和移植数据库收集数据,包括与肾移植有关的人口特征和感染测试。将收集到的信息输入SPSS18软件。结果:受试者年龄从10岁到73岁不等,其中125例因ERDS导致肾衰竭。肾移植患者弓形虫暴露率为54.2%。125例因ERDS导致肾衰竭的患者。在肾移植患者中,弓形虫暴露率为54.2%。TOX IgG与年龄呈正相关(r= 0.12, P = 0.02)。CMV IgG与肾移植时间呈正相关(r = 0.11, P = 0.03), TOX IgG与肾移植时间呈正相关(r = 0.13, P < 0.01)。发现性别不能预测EBV。IgG (β = 0.787, p), CMV;IgG (β = 4.752, p TOX;结论:临床医师应注意预防措施,对症状一致的病例应考虑早期诊断。建议在潜在供体中筛查抗弓形虫IgM抗体。
{"title":"Seroepidemiology of <i>toxoplasma gondii</i> in kidney transplant patients.","authors":"Marzieh Latifi, Habib Rahban, Elahe Pourhosein, Tannaz Hajialireza Tehrani, Parisa Mahjoobi, Sanaz Dehghani","doi":"10.22088/cjim.16.3.507","DOIUrl":"10.22088/cjim.16.3.507","url":null,"abstract":"<p><strong>Background: </strong>Opportunistic infection after transplantation is a serious problem, with <i>Toxoplasma Gondii (T.gondii)</i> and cytomegalovirus being the most concerning infections. The objective of this research was to examine the seroepidemiology of the <i>T. gondii</i> virus among kidney transplant recipients at Sina Hospital in Tehran from 2017 to 2021.</p><p><strong>Methods: </strong>A total of 342 kidney transplant patients participated in this cross-sectional study using the census method after obtaining consent. Data were collected by reviewing medical records and the transplant database, including demographic characteristics and infectious tests related to kidney transplantation. The collected information was entered into SPSS18 software.</p><p><strong>Results: </strong>The age of the subjects ranged from 10 to 73 years, with 125 patients having kidney failure due to ERDS. The rate of exposure to T. gondii in kidney transplant patients was 54.2%. 125 patients experiencing kidney failure due to ERDS. In kidney transplant patients, the exposure rate to <i>T. gondii</i> was 54.2%. There is a positive correlation between <i>TOX IgG</i> and age (r= 0.12, P = 0.02). There is a positive correlation between <i>CMV IgG</i> and the time elapsed since kidney transplantation (r = 0.11, P = 0.03) and <i>TOX IgG</i> (r = 0.13, p < 0.01). Gender was found not to predict <i>EBV.IgG</i> (β = 0.787, p < 0.21<i>), CMV.IgG</i> (β = 4.752, p < 0.071), <i>TOX.IgG</i> (β = 1.154, p < 0.256) based on regression tests.</p><p><strong>Conclusion: </strong>Physicians should be aware of preventive measures and should consider early diagnosis in cases of compatible symptoms. Screening for anti-Toxoplasma IgM antibodies in potential donors is recommended.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"507-512"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum fibrinogen & total cholesterol: A significant primary biomarker and its interrelationship in stroke. 血清纤维蛋白原和总胆固醇:卒中中重要的主要生物标志物及其相互关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.525
Komal Rana, Tarunkumar Chavda, Sonal Chavda, Chetan Sonkar, Krishna Soni, Krina Patel, Nancy Vaja, Saniya Vahora, Amal Kumar Bhattacharya

Background: To study the association of plasma fibrinogen & total cholesterol levels, incidences, prevalence, and gender wise distribution in different etiologies of stroke.

Methods: Fibrinogen & total cholesterol levels, prevalence, incidences, comorbidities, and different etiologies were assessed along with routine investigations and radiology inputs as per investigator's discretion. The overall median values were represented in graphically format in MS-Excel.

Results: 292 Males: 218 females. Age 30 to 80 years. Among, 25.1% diabetic, 38.9 % hypertension (HTN) and 31% diabetes + HTN. 5 % diabetes + HTN + dyslipidemia and other comorbidities. Overall, 73% had ischemic stroke (IS) & 27 % have hemorrhagic stroke (HS). Hemiparesis in 76.5 %. Mean Fibrinogen elevated in 81% and range was 934±20 mg/dL. Total cholesterol level increased in 73.2% & range was 365±10 mg/dL. The HS patients were experienced headache 77 (19.60%) and vomiting 34 (24.6%) than IS patients. As per radiological finding, the territory of Middle Cerebral Artery was the ordinary location of arterial territory infarctions in the IS form that was present in 213 (57.2%) subjects following that in the anterior side of cerebral artery in 89 (23.92%) and posterior cerebral artery was 44 (11.82%). Arterial flutter found in 56 (10.9%), Structural heart disease present in 30 (5.88%), family history of stroke in 28 (5.49%).

Conclusion: Elevated fibrinogen & total cholesterol levels are independent significant primary biomarkers elevated with incidences of CV stroke. Stroke was higher in ischemic stroke group.

背景:研究血浆纤维蛋白原与总胆固醇水平的关系、卒中不同病因的发病率、患病率及性别分布。方法:评估纤维蛋白原和总胆固醇水平、患病率、发病率、合并症和不同病因,并根据研究者的判断进行常规检查和放射学输入。总体中位数在MS-Excel中以图形格式表示。结果:男性292人,女性218人。年龄在30至80岁之间。其中,糖尿病占25.1%,高血压(HTN)占38.9%,糖尿病+ HTN占31%。5%糖尿病+ HTN +血脂异常及其他合并症。总体而言,73%为缺血性卒中(IS), 27%为出血性卒中(HS)。偏瘫76.5%。平均纤维蛋白原升高81%,范围为934±20 mg/dL。总胆固醇水平升高73.2%,范围为365±10 mg/dL。HS患者头痛77例(19.60%),呕吐34例(24.6%)。影像学显示,213例(57.2%)患者出现IS型动脉梗死,其次是89例(23.92%)脑前动脉梗死,44例(11.82%)脑后动脉梗死。动脉扑动56例(10.9%),结构性心脏病30例(5.88%),卒中家族史28例(5.49%)。结论:纤维蛋白原和总胆固醇水平升高是心血管卒中发病率升高的独立、重要的主要生物标志物。缺血性脑卒中组卒中发生率较高。
{"title":"Serum fibrinogen & total cholesterol: A significant primary biomarker and its interrelationship in stroke.","authors":"Komal Rana, Tarunkumar Chavda, Sonal Chavda, Chetan Sonkar, Krishna Soni, Krina Patel, Nancy Vaja, Saniya Vahora, Amal Kumar Bhattacharya","doi":"10.22088/cjim.16.3.525","DOIUrl":"10.22088/cjim.16.3.525","url":null,"abstract":"<p><strong>Background: </strong>To study the association of plasma fibrinogen & total cholesterol levels, incidences, prevalence, and gender wise distribution in different etiologies of stroke.</p><p><strong>Methods: </strong>Fibrinogen & total cholesterol levels, prevalence, incidences, comorbidities, and different etiologies were assessed along with routine investigations and radiology inputs as per investigator's discretion. The overall median values were represented in graphically format in MS-Excel.</p><p><strong>Results: </strong>292 Males: 218 females. Age 30 to 80 years. Among, 25.1% diabetic, 38.9 % hypertension (HTN) and 31% diabetes + HTN. 5 % diabetes + HTN + dyslipidemia and other comorbidities. Overall, 73% had ischemic stroke (IS) & 27 % have hemorrhagic stroke (HS). Hemiparesis in 76.5 %. Mean Fibrinogen elevated in 81% and range was 934±20 mg/dL. Total cholesterol level increased in 73.2% & range was 365±10 mg/dL. The HS patients were experienced headache 77 (19.60%) and vomiting 34 (24.6%) than IS patients. As per radiological finding, the territory of Middle Cerebral Artery was the ordinary location of arterial territory infarctions in the IS form that was present in 213 (57.2%) subjects following that in the anterior side of cerebral artery in 89 (23.92%) and posterior cerebral artery was 44 (11.82%). Arterial flutter found in 56 (10.9%), Structural heart disease present in 30 (5.88%), family history of stroke in 28 (5.49%).</p><p><strong>Conclusion: </strong>Elevated fibrinogen & total cholesterol levels are independent significant primary biomarkers elevated with incidences of CV stroke. Stroke was higher in ischemic stroke group.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"525-535"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Caspian Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1